Frank Christian Dr. Richard Email & Phone Number

Ladenburg, Baden-Württemberg, De

In my role as VP Medical, I am providing medical strategy and oversight for the preparation and conduct of phase I-III clinical studies using ADCs and work closely with a cross-functional team. Additionally, I support modelling &simulation activities to understand how to effectively use preclinical data from in vivo studies, mechanistic modeling, and bioanalysis to improve dose prediction and determine the optimal dose when introducing an ADC into clinical trials in various cancer indications.Heidelberg Pharma AG is proud to be featured in Clarivate's Companies to Watch report, highlighting the most exciting companies in the ADC space right now. To learn more about our innovative approach to #ADCs using #amanitin-based compounds as the payload, read the full report at the link below. #HeidelbergPharmahttps://lnkd.in/eCSaAWtu

Prague 9, Czech Republic, Cz

I have spearheaded the clinical development strategy of novel immunotherapeutic candidates and CAR-T cell therapies as well as guided ADC Clinical Pharmacology aspects, leading to several clinical stage trials. Furthermore, I have actively collaborated with external partners, including academic institutions and contract research organizations, to accelerate the progression of projects in a time-efficient and cost-effective manner. At the same time I was appointed as the Company Clinical Pharmacology Lead and fostered my background in Bayesian Statistics, Modelling& Simulation and Machine Learning.

St. Gallen, Switzerland, Ch

With a solid foundation in adaptive trial designs, I have implemented innovative methodologies into practice. The oral ferroportin inhibitor vamifeport was designed to improve iron homeostasis and erythropoiesis in β-thalassemia. I have been instrumental in bringing several early phase studies in healthy volunteers and rare disease patients into clinics.

Basel, Basel-Stadt, Ch

Medical supervision and development strategy of biosimilars in the therapeutic area Immunology

Ingelheim Am Rhein, Rhineland-Palatinate, De

• Actively contributed as a distinguished member of the global Medical Affairs team for Spiriva®, specializing in Chronic Obstructive Pulmonary Disease (COPD)• Collaborated in the development and co-authorship of various secondary publications for Spiriva® in the field of COPD, raising scientific knowledge and promoting its efficacy

Tokyo, Jp

Clinical Science Immunology & Respiratory, TDC Europe;Global clinical team lead of FiM compound in pulmonary fibrosis, study team lead for PoC trial in severe asthma, preparation/ support of clinical trial documents incl. study outlines, clinical trial protocols, CTA/ IND core documents and clinical trial reports within therapeutic area, support product positioning and key selling propositions, project related medical scientific representation internal and external

Medical Scientific Strategy

Leverkusen, North Rhine-Westphalia, De

Global Clinical Pharmacology Womens' Healthcare,2001-2007:Specialist education program in “Clinical Pharmacology”• Study team Lead and Medical Head of Trial Unit• Member of the International project team• Planning of CP studies, work steps, resources, timeframes in accordance with Masterplan• Prepare and update CP-sections of IB, dossiers, package inserts• Supporting of GO/NO GO decisions

Durham, North Carolina, Us

Planning, Submission, Conduct, Reporting of Clinical Studies Phase I-II

Doctor Of Medicine (M.D.), Human Medicine

Master'S Degree (Mba), Business Administration And Health Economics

Physikum, Human Medicine